160 related articles for article (PubMed ID: 33021390)
1. Construction prognosis model based on autophagy-related gene signatures in hepatocellular carcinoma.
Wang J; Miao Y; Ran J; Yang Y; Guan Q; Mi D
Biomark Med; 2020 Sep; 14(13):1229-1242. PubMed ID: 33021390
[No Abstract] [Full Text] [Related]
2. Development and Validation of an Autophagy-Related Gene Signature for Predicting the Prognosis of Hepatocellular Carcinoma.
Zhang J; Zhang M; Huang J; Zhang G; Li C; Wang X; Kong W
Biomed Res Int; 2021; 2021():7771037. PubMed ID: 34746309
[TBL] [Abstract][Full Text] [Related]
3. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5.
Xu R; Lin L; Zhang B; Wang J; Zhao F; Liu X; Li Y; Li Y
BMC Cancer; 2021 Jun; 21(1):687. PubMed ID: 34112092
[TBL] [Abstract][Full Text] [Related]
4. An Autophagy-Related Gene-Based Prognostic Risk Signature for Hepatocellular Carcinoma: Construction and Validation.
Feng R; Li J; Xuan W; Liu H; Cheng D; Wang G
Comput Math Methods Med; 2021; 2021():5770228. PubMed ID: 34691238
[TBL] [Abstract][Full Text] [Related]
5. ATIC inhibits autophagy in hepatocellular cancer through the AKT/FOXO3 pathway and serves as a prognostic signature for modeling patient survival.
Zhang H; Xia P; Liu J; Chen Z; Ma W; Yuan Y
Int J Biol Sci; 2021; 17(15):4442-4458. PubMed ID: 34803509
[No Abstract] [Full Text] [Related]
6. [Prognosis prediction model for hepatocellular carcinoma based on autophagy related genes].
Huang W; Han N; Du L; Cao D; Tang H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2022 Feb; 39(1):120-127. PubMed ID: 35231973
[TBL] [Abstract][Full Text] [Related]
7. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
8. Identification of an autophagy-related gene signature that can improve prognosis of hepatocellular carcinoma patients.
Huo X; Qi J; Huang K; Bu S; Yao W; Chen Y; Nie J
BMC Cancer; 2020 Aug; 20(1):771. PubMed ID: 32807131
[TBL] [Abstract][Full Text] [Related]
9. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
[TBL] [Abstract][Full Text] [Related]
10. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
[TBL] [Abstract][Full Text] [Related]
11. m
Wu Y; Li L; Wang L; Zhang S; Zeng Z; Lu J; Wang Z; Zhang Y; Zhang S; Li H; Chen T
BMC Cancer; 2024 Apr; 24(1):506. PubMed ID: 38649860
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study.
Wang Y; Huang Q; Deng T; Li BH; Ren XQ
Med Sci Monit; 2019 May; 25():3894-3901. PubMed ID: 31128068
[TBL] [Abstract][Full Text] [Related]
13. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
[TBL] [Abstract][Full Text] [Related]
14. A gene-based risk score model for predicting recurrence-free survival in patients with hepatocellular carcinoma.
Wang W; Wang L; Xie X; Yan Y; Li Y; Lu Q
BMC Cancer; 2021 Jan; 21(1):6. PubMed ID: 33402113
[TBL] [Abstract][Full Text] [Related]
15. Role of autophagy-related genes in liver cancer prognosis.
Zhou Y; Shan R; Xie W; Zhou Q; Yin Q; Su Y; Xiao J; Luo P; Yao X; Fang J; Wen F; Shen E; Weng J
Genomics; 2024 May; 116(3):110852. PubMed ID: 38703969
[TBL] [Abstract][Full Text] [Related]
16. A novel focal adhesion related gene signature for prognostic prediction in hepatocellular carcinoma.
Lin Z; Miao D; Xu Q; Wang X; Yu F
Aging (Albany NY); 2021 Apr; 13(7):10724-10748. PubMed ID: 33850056
[TBL] [Abstract][Full Text] [Related]
17. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
18. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
Front Immunol; 2021; 12():653836. PubMed ID: 33897701
[No Abstract] [Full Text] [Related]
19. Exploration and validation of a novel prognostic signature based on comprehensive bioinformatics analysis in hepatocellular carcinoma.
Wang X; Qiao J; Wang R
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33111935
[TBL] [Abstract][Full Text] [Related]
20. Eight-gene metabolic signature related with tumor-associated macrophages predicting overall survival for hepatocellular carcinoma.
Huo J; Wu L; Zang Y; Dong H; Liu X; He F; Zhang X
BMC Cancer; 2021 Jan; 21(1):31. PubMed ID: 33413205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]